Tibet Duo Rui Pharmaceutical: Announcement on the progress of share repurchase and completion of the repurchase
Dorui Pharmaceuticals: Announcement on the 2023 Profit Distribution Plan
Dorui Pharmaceuticals: Progress Announcement on the Repurchase of the Company's Shares
Dorui Pharmaceuticals: Announcement on the repurchase ratio of the company\'s shares reaching 1%
Dorui Pharmaceuticals: Progress Announcement on Share Repurchase
Dorui Pharmaceuticals: Top 10 Shareholders and Top 10 Shareholders with Unlimited Terms of Sale in relation to share repurchases
Dorui Pharmaceuticals: Repurchase Report
Dorui Pharmaceuticals: Announcement on the plan to repurchase the company\'s shares
Dorui Pharmaceuticals: Announcement on the completion of the shareholders\' holdings reduction plan
Dorui Pharmaceutical: Announcement on the release of the pledge of some of the controlling shareholders\' shares
Dorui Pharmaceutical: Shareholders\' Announcement on Reducing the Company\'s Shares to 1%
Doray Pharmaceuticals: Simplified Equity Change Report
Dorui Pharmaceutical: Prompt announcement on changes in shareholders\' equity and shareholding ratio to fall below 5%
Dory Pharmaceuticals: Shareholders\' Announcement on Reducing Company Shares to or More Than 1%
Dorui Pharmaceutical: Announcement on Applying for M&A Loans from Banks and Pledging Shares for Underpinned Companies
Dory Pharmaceuticals: Pre-disclosure Notice Concerning Shareholders Holding 5% or More to Reduce Their Shareholding
Dori Pharmaceutical: Announcement on the completion of a plan to reduce the holdings of shareholders holding 5% or more of the shares
Dory Pharmaceuticals: Announcement on 2022 Profit Distribution Plan
Dory Pharmaceuticals: Announcement on the progress of shareholders holding 5% or more of the share holdings reduction plan to reduce their holdings by more than half
Dory Pharmaceuticals: Shareholders' Announcement on Reducing Company Shares to or More Than 1%
No Data